Sucheol Gil

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model”.

In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model

Molecular Therapy(2020)10.1016/j.ymthe.2020.09.001

N/A

0DataRank · unranked

70 citations

Hongjie Wang, Aphrodite Georgakopoulou, Sucheol Gil, Evangelia Yannaki, Andre Lieber +1 more

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

Blood Advances(2021)10.1182/bloodadvances.2020003702

N/A

0DataRank · unranked

90 citations

Aphrodite Georgakopoulou, Arpit Mishra, Sucheol Gil, R. David Hawkins, Evangelia Yannaki +2 more

Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.12.003

N/A

0DataRank · unranked

46 citations

Hongjie Wang, Sucheol Gil, Audrey Germond, Connie Fountain, Audrey Baldessari +14 more

Translational Development of A Tumor Junction Opening Technology

Research Square(2021)10.21203/rs.3.rs-1075411/v1

N/A

0DataRank · unranked

0 citations

Chang Li, Hongjie Wang, Swarnendu Kaviraj, Sanjay Singh, Laxman Savergave +11 more

In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4

Blood Advances(2022)10.1182/bloodadvances.2022007975

N/A

0DataRank · unranked

30 citations

Audrey Germond, Chang Li, Sucheol Gil, Jiho Kim, Hans‐Peter Kiem +2 more

In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor

Human Gene Therapy(2022)10.1089/hum.2021.295

N/A

0DataRank · unranked

10 citations

Chang Li, Adebimpe Obadan, Hannah Frizzell, Tien-Ying Hsiang, Sucheol Gil +8 more

Translational development of a tumor junction opening technology

Scientific Reports(2022)10.1038/s41598-022-11843-z

N/A

0DataRank · unranked

8 citations

Chang Li, Hongjie Wang, Swarnendu Kaviraj, Sanjay Singh, Laxman Savergave +11 more

HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.03.008

N/A

0DataRank · unranked

22 citations

Aphrodite Georgakopoulou, Wenli Zhang, Jiho Kim, Sucheol Gil, Anja Ehrhardt +2 more

Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIV

Molecular Therapy(2023)10.1016/j.ymthe.2023.02.002

N/A

0DataRank · unranked

6 citations

Anna Kate Anderson, Hongjie Wang, Sucheol Gil, Jiho Kim, Lishan Huang +9 more

Introducing a hemoglobin G-Makassar variant in HSCs by in vivo base editing treats sickle cell disease in mice

Molecular Therapy(2024)10.1016/j.ymthe.2024.10.018

N/A

0DataRank · unranked

17 citations

Aphrodite Georgakopoulou, Kiriaki Paschoudi, Anna Kate Anderson, Lishan Huang, Sucheol Gil +8 more